Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data

Blaj, Sebastian and Leebmann, H. and Babucke, Maximilian and Acs, M. and Piso, Pompiliu (2024) Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data. CLINICAL COLORECTAL CANCER, 23 (4). pp. 309-317. ISSN 1533-0028, 1938-0674

Full text not available from this repository. (Request a copy)

Abstract

The peritoneal metastasized colorectal cancer (pmCRC) represents a serious health problem worldwide with a special emphasis in the developed countries. Several guidelines recognize the role of multimodal therapy consisting of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of pmCRC. New data suggests that some other factors, eg, tumor biology, immune profile, neoadjuvant chemotherapy may play a predictive role for the oncological outcome of these patients. Clinical Colorectal Cancer, Vol. 23, No. 4, 309-317 (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Item Type: Article
Uncontrolled Keywords: HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; RANDOMIZED-TRIAL; HIGH-RISK; METASTASES; MANAGEMENT; THERAPY; METAANALYSIS; DIAGNOSIS; Clinical trials; Colorectal cancer; Cytoreductive surgery (CRS); Hyperthermic Intraperitoneal Chemotherapy (HIPEC); Peritoneal metastases
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 15 Jul 2025 09:07
Last Modified: 15 Jul 2025 09:07
URI: https://pred.uni-regensburg.de/id/eprint/63450

Actions (login required)

View Item View Item